Cullinan Oncology, Inc. (CGEM)
Total Valuation
CGEM has a market cap or net worth of $763.55 million. The enterprise value is $300.08 million.
Market Cap | 763.55M |
Enterprise Value | 300.08M |
Important Dates
The last earnings date was Thursday, March 14, 2024, before market open.
Earnings Date | Mar 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CGEM has 43.07 million shares outstanding. The number of shares has decreased by -10.91% in one year.
Shares Outstanding | 43.07M |
Shares Change (YoY) | -10.91% |
Shares Change (QoQ) | +0.18% |
Owned by Insiders (%) | 7.15% |
Owned by Institutions (%) | 94.74% |
Float | 25.88M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.68 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.07, with a Debt / Equity ratio of 0.01.
Current Ratio | 17.07 |
Quick Ratio | n/a |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -32.10% and return on invested capital (ROIC) is -41.79%.
Return on Equity (ROE) | -32.10% |
Return on Assets (ROA) | -30.40% |
Return on Capital (ROIC) | -41.79% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.80M |
Employee Count | 85 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -14.12M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +62.60% in the last 52 weeks. The beta is 0.34, so CGEM's price volatility has been lower than the market average.
Beta (1Y) | 0.34 |
52-Week Price Change | +62.60% |
50-Day Moving Average | 16.53 |
200-Day Moving Average | 11.57 |
Relative Strength Index (RSI) | 52.96 |
Average Volume (30 Days) | 425,070 |
Short Selling Information
The latest short interest is 935,407, so 2.17% of the outstanding shares have been sold short.
Short Interest | 935,407 |
Short Previous Month | 694,101 |
Short % of Shares Out | 2.17% |
Short % of Float | 3.62% |
Short Ratio (days to cover) | 1.27 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -191.09M |
Pretax Income | -167.28M |
Net Income | -153.16M |
EBITDA | -166.97M |
EBIT | -167.28M |
Earnings Per Share (EPS) | -$3.69 |
Balance Sheet
The company has $467.07 million in cash and $3.59 million in debt, giving a net cash position of $463.48 million or $10.76 per share.
Cash & Cash Equivalents | 467.07M |
Total Debt | 3.59M |
Net Cash | 463.48M |
Net Cash Per Share | $10.76 |
Equity / Book Value | 453.70M |
Book Value Per Share | 10.54 |
Working Capital | 452.05M |
Cash Flow
In the last 12 months, operating cash flow was -$134.28 million and capital expenditures -$208,000, giving a free cash flow of -$134.48 million.
Operating Cash Flow | -134.28M |
Capital Expenditures | -208,000 |
Free Cash Flow | -134.48M |
FCF Per Share | -$3.24 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CGEM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 10.91% |
Shareholder Yield | 10.91% |
Earnings Yield | -20.06% |
FCF Yield | -17.61% |
Analyst Forecast
The average price target for CGEM is $28.67, which is 68.25% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $28.67 |
Price Target Difference | 68.25% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |